Clinical Guides
Emergency Contraception
A source-grounded guide to time-critical emergency contraception, method selection, follow-up and India-specific service context, prepared for mandatory specialist review before publication.
MedNext Academy | 14 min read
Emergency Contraception
A source-grounded guide to time-critical emergency contraception, method selection, follow-up and India-specific service context, prepared for mandatory specialist review before publication.
Summary
Emergency contraception reduces the chance of pregnancy after unprotected vaginal intercourse, contraceptive failure or sexual assault. It should be offered as soon as possible and must not be confused with abortion care: emergency contraceptive pills mainly prevent or delay ovulation, while a copper intrauterine device prevents fertilisation, and neither interrupts an established pregnancy. The available methods in WHO guidance are a copper-bearing IUD and emergency contraceptive pills containing ulipristal acetate, levonorgestrel, or a combined oestrogen-progestogen Yuzpe regimen. The copper IUD is the most effective option and can also provide ongoing contraception. Oral methods are valuable when insertion is declined, unavailable or unsuitable.
The consultation is time-critical but still requires consent, privacy and a focused safety assessment. Establish when each episode of unprotected intercourse occurred, the last normal menstrual period, the method that failed, current medicines, breastfeeding, pregnancy possibility, sexual-assault or safeguarding needs, and whether an ongoing method is wanted. A pregnancy test can identify an existing pregnancy but cannot exclude conception from very recent intercourse; testing must not create an avoidable delay in giving an appropriate pill.
Emergency contraception does not protect against later intercourse in the same cycle and does not prevent sexually transmitted infections. Give clear instructions about starting or resuming regular contraception, condom use, vomiting, expected bleeding changes, pregnancy testing and urgent symptoms. This quarantined educational guide is not an individual prescription or an insertion protocol and has been reviewed by the MedNext Clinical Team.
How Common Is It?
Emergency contraception is needed wherever contraception is unavailable, omitted, used incorrectly or fails. Relevant scenarios include no method, condom breakage or slippage, missed oral contraceptive pills, a late injection, expulsion of an IUD, failed withdrawal, miscalculation of a fertility-awareness method, and sexual assault without reliable protection. The need cannot be estimated from clinic attendance alone because many people obtain levonorgestrel directly from a pharmacy, do not know that a copper IUD is an option, face stigma, or cannot reach a trained inserter within the useful window.
WHO frames emergency contraception as a routine component of comprehensive contraceptive care rather than a rare exception. Any woman or adolescent of reproductive age who may need it can use emergency contraceptive pills; there is no absolute medical contraindication to the pills in WHO’s fact sheet. Eligibility for a copper IUD is different because insertion and method-specific conditions must be assessed. Repeated need for emergency contraception is not evidence of irresponsibility. It is an opportunity to identify access problems, coercion, misunderstanding, an unsuitable regular method or a preference for an on-demand approach.
This guide deliberately gives no Indian prevalence percentage. Sales data omit public supply and do not prove use; programme distributions do not prove ingestion; and surveys vary in wording and population. The defensible clinical message is that need is common, access is unequal and delay reduces oral-method effectiveness. Services should therefore make accurate information and rapid, non-judgemental access available before an emergency occurs.
Risk Factors
The immediate risk of pregnancy depends on whether semen entered the vagina, timing relative to ovulation, cycle variability and whether more than one unprotected episode occurred. Calendar calculations cannot reliably prove that a person is outside the fertile window, especially with irregular cycles, recent childbirth, breastfeeding, emergency-pill use earlier in the cycle or uncertain dates. Do not deny emergency contraception solely because an app labels the day low risk. Ask about all unprotected intercourse since the last normal period because a method given today cannot reverse an established pregnancy from an earlier exposure.
Contraceptive failures have method-specific clues: missed active pills, delayed patch or ring changes, late injections, broken or displaced condoms, vomiting or severe diarrhoea affecting pill absorption, and medicines that induce drug-metabolising enzymes. Current or recent enzyme-inducing medicines may reduce oral emergency-contraceptive effectiveness, so a copper IUD is generally the preferred effective option when eligible and acceptable; local product information and specialist advice should determine any alternative. Higher body weight or BMI may also reduce the effectiveness of emergency contraceptive pills, particularly levonorgestrel, although WHO says access should not be denied on that basis.
Risks relevant to method choice are not the same as pregnancy risk. For copper-IUD insertion, assess current pelvic infection, puerperal sepsis, unexplained vaginal bleeding, distorted uterine cavity, cervical or endometrial malignancy, copper allergy or Wilson disease according to current eligibility guidance and product information. Sexual assault raises pregnancy, STI, HIV, injury, coercion and safeguarding concerns. It requires trauma-informed comprehensive care, not merely a tablet, and an IUD should not be assumed appropriate when STI risk or consent makes insertion unsafe.
Diagnosis
Emergency contraception is a preventive intervention, not a disease diagnosis. The clinical task is to establish whether an exposure capable of causing pregnancy occurred, whether the person is within a useful treatment window, whether pregnancy may already exist, and which method is safe and acceptable. Act promptly while preserving voluntary decision-making and confidentiality.
History
Record the date and approximate time of every unprotected vaginal intercourse since the last normal period, usual cycle pattern, first day of the last period, recent pregnancy, birth, miscarriage or abortion, and any pregnancy symptoms. Clarify the failed method and exact error. Ask about allergies, current medicines including over-the-counter and herbal products, enzyme inducers, severe illness, breastfeeding and preferences for ongoing contraception. For a possible IUD, ask about pelvic pain, fever, abnormal discharge, STI exposure, previous ectopic pregnancy, uterine disease and unexplained bleeding. Ask privately about assault, coercion, age-related safeguarding and immediate safety.
Examination
No physical or pelvic examination is required merely to provide an emergency contraceptive pill. Check observations and examine only when symptoms suggest acute illness, pregnancy complication, injury or infection. Copper-IUD placement requires a trained provider, consent, appropriate pelvic assessment and aseptic technique. Trauma-informed care should minimise repeated examination after assault and coordinate forensic needs according to the person’s choices and local law.
Investigations
A urine pregnancy test is useful when a period is late, earlier intercourse could have led to pregnancy, or an IUD is considered, but a negative result cannot exclude a pregnancy from recent exposure. Do not delay an appropriate pill while awaiting unnecessary tests. STI and HIV testing are risk-based and should be offered with appropriate window-period advice; emergency contraception itself does not require routine blood tests or ultrasound. Pain, bleeding or a positive pregnancy test requires a pregnancy-location pathway rather than routine emergency contraception alone.
Differential Diagnosis
The main distinction is between risk of a new pregnancy and an already established pregnancy. Emergency contraception cannot treat an existing intrauterine or ectopic pregnancy. A late or unusually light period, pregnancy symptoms, prior unprotected intercourse earlier in the cycle or a positive test should prompt appropriate pregnancy assessment. Severe unilateral pain, shoulder-tip pain, syncope or haemodynamic disturbance raises concern for ectopic pregnancy and needs urgent evaluation; previous emergency-pill use does not explain away those symptoms.
Clarify whether the event was truly an exposure likely to cause pregnancy. Oral sex, intact condom use without semen leakage, and contact without vaginal semen exposure do not carry the same pregnancy risk, although STI or assault care may still be necessary. Conversely, attempted withdrawal, uncertain ejaculation, semen near the vulva, condom mishap, missed hormonal contraception and an expelled device can create risk that is difficult to quantify. Avoid false reassurance based on a single cycle-day estimate.
Abnormal bleeding after emergency contraception may be a transient drug effect, the next menstrual period, early pregnancy bleeding, miscarriage, ectopic pregnancy, infection or unrelated gynaecological disease. Nausea, breast tenderness and fatigue can follow a pill but also occur in pregnancy. Pelvic pain, fever or purulent discharge suggests infection rather than an expected medication effect.
The broader assessment after sexual assault includes genital or other injury, STI exposure, HIV exposure, hepatitis B risk, intoxication, acute psychological distress, coercive control and safeguarding needs. These are parallel diagnoses and risks; offering emergency contraception must never close the consultation before they are addressed.
Management
Offer the most effective suitable method as soon as possible. WHO states that a copper-bearing IUD inserted within 120 hours of unprotected intercourse is more than 99% effective and can remain for ongoing contraception. It requires a trained provider and current IUD eligibility assessment. If it is declined, inaccessible or contraindicated, offer an oral method without avoidable delay. WHO regimens include ulipristal acetate 30 mg once, levonorgestrel 1.5 mg once, or the less effective and less well-tolerated combined Yuzpe regimen where dedicated products are unavailable. Verify the locally authorised product and protocol rather than extrapolating from this educational text.
Earlier oral use is generally more effective. Ulipristal maintains greater effectiveness than other pills between 72 and 120 hours in WHO’s summary. A copper IUD remains the preferred method when very high effectiveness, ongoing contraception, higher weight or enzyme-inducing medicines are important and the patient is eligible. Respect a decision against insertion. Do not substitute coercive counselling about a regular method for immediate access.
After levonorgestrel or combined pills, WHO permits immediate start or resumption of a regular method. After ulipristal, progestogen-containing contraception is started on day six because earlier progestogen may reduce ulipristal’s ovulation-delaying effect. Barrier precautions and method-specific backup are needed. An IUD provides ongoing contraception immediately. Explain that oral emergency contraception gives no protection from subsequent unprotected intercourse.
Provide written safety-netting, a pregnancy-test plan and STI prevention advice. After assault, integrate HIV post-exposure prophylaxis assessment, STI care, hepatitis B vaccination when indicated, injury treatment, psychosocial support, forensic options and safeguarding under local pathways.
Prescribing Information
This is a verification framework, not a patient-specific prescription. Confirm the product, active ingredient, dose, timing, interactions, expiry, contraindications and follow-up from current Indian labelling and local guidance. WHO lists levonorgestrel 1.5 mg as a single dose, ulipristal acetate 30 mg as a single dose, and a divided levonorgestrel alternative of 0.75 mg twice 12 hours apart. Dedicated single-dose products reduce administration error. The Yuzpe regimen causes more nausea and vomiting and should not displace a suitable dedicated product or copper IUD.
If vomiting occurs within two hours of taking an emergency contraceptive pill, WHO advises repeating the dose. Persistent vomiting requires clinical or pharmacy advice about redosing and an alternative method. Expected short-term effects include nausea, fatigue, headache, cramping, spotting and a period that comes somewhat earlier or later. These effects are usually self-limited. Severe pain, collapse, very heavy bleeding, allergy symptoms or later pregnancy symptoms are not routine side effects.
Review enzyme-inducing medicines and use current interaction guidance. Do not improvise double dosing without a verified protocol. Higher BMI may reduce oral effectiveness, but it is not a reason to withhold treatment. An emergency pill has no role in ending an established pregnancy; inadvertent levonorgestrel exposure is not an indication for abortion.
Starting ongoing contraception differs by pill type. Progestogen-containing methods can be started immediately after levonorgestrel, with method-specific barrier backup. Delay progestogen initiation until the sixth day after ulipristal and use condoms or abstain meanwhile and through the required backup interval. Document the chosen plan. Copper-IUD counselling must cover insertion, expected bleeding, expulsion, infection and perforation warnings, strings advice and removal access.
When to Refer
Arrange same-day referral to a trained contraceptive provider when a copper IUD is requested and can still be placed within the recommended window. The referral must be rapid and should not become a barrier: if timely insertion cannot be assured, discuss and offer an appropriate oral method while preserving the option of IUD assessment. Seek specialist contraceptive or pharmacy advice for complex enzyme-inducing treatment, uncertain timing after multiple exposures, bariatric or malabsorption concerns, serious comorbidity, or uncertainty about starting a regular hormonal method after ulipristal.
Refer urgently for a positive pregnancy test with pain or bleeding, severe lower abdominal pain, syncope, shoulder-tip pain, haemodynamic instability, significant genital injury, uncontrolled bleeding, fever or sepsis. These findings require assessment for ectopic pregnancy, miscarriage, infection or trauma rather than routine EC follow-up. A pregnancy that occurs despite emergency contraception warrants pregnancy-options counselling and location assessment according to symptoms; the failure is not evidence that the patient used the method incorrectly.
Sexual assault requires access to a coordinated pathway. Depending on timing and circumstances, this may include emergency medicine, sexual-assault services, paediatrics, infectious diseases, mental health, social work and police or forensic services chosen within applicable consent and reporting law. Assess HIV post-exposure prophylaxis urgently because its window is short.
Routine follow-up can remain in primary care or family-planning services when there are no complications. Refer for repeated contraceptive failure if a difficult regimen, interaction, coercion, reproductive-health condition or desire for a procedure needs specialist input. The goal is reliable choice, not judgement about repeated EC use.
Red Flags
Immediate medical assessment is needed for collapse, fainting, severe or one-sided pelvic pain, shoulder-tip pain, breathlessness, marked weakness, haemodynamic disturbance or heavy continuing bleeding. These may signal ectopic pregnancy, ruptured ovarian pathology, miscarriage, haemorrhage or another acute condition. A negative test performed soon after intercourse does not exclude pregnancy, and a history of taking emergency contraception must not lower clinical vigilance. Fever, worsening pelvic pain, purulent discharge or severe uterine tenderness after IUD insertion raises concern for infection; inability to feel threads alone is not an emergency, but pregnancy risk, pain or abnormal bleeding changes urgency.
After an oral method, urticaria, facial swelling, breathing difficulty or persistent vomiting requires urgent advice. A period more than about one week late, substantially lighter than usual, or absent by three weeks after the exposure should trigger pregnancy testing under the agreed plan. A positive result needs assessment and non-directive pregnancy-options counselling. Emergency pills do not cause abortion and should not delay appropriate abortion care when that is the patient’s lawful choice.
Safeguarding red flags include sexual assault, reproductive coercion, inability to consent, exploitation, trafficking, intimate-partner violence, threats, or a child below the applicable age threshold. Ensure privacy, immediate safety and local statutory safeguarding procedures without making promises of absolute confidentiality that the law does not permit.
HIV exposure within the post-exposure-prophylaxis window, major genital injury or suspected drug-facilitated assault is time-critical. Emergency contraception is only one element of care. Provide explicit contact details and instructions, because vague advice to return if worried is inadequate safety-netting.
Indian Clinical Context
India’s Family Planning Division issued a dedicated emergency-contraceptive-pill provider guideline in November 2008. It records that levonorgestrel was approved for emergency contraception in 2001 and introduced into the public Family Welfare Programme in 2003, and it emphasises access irrespective of age or marital status. That programme history remains useful, but the manual is old: its preferred 72-hour framing and several details predate the current WHO five-day framework and 2025 medical eligibility guidance. Current WHO guidance and verified Indian product information should therefore control time windows, interactions and method selection.
Levonorgestrel emergency pills are widely recognised in Indian public and retail settings. Availability of ulipristal, trained copper-IUD insertion, same-day STI testing and comprehensive sexual-assault care varies by district, facility and sector. This guide does not claim nationwide stock or over-the-counter status for every product. A clinician should identify what can actually be delivered now, avoid delaying a pill for an uncertain referral, and document options that were unavailable.
Counselling must be confidential, non-judgemental and understandable. Marital status is not a biological eligibility criterion. For adolescents and assault survivors, apply current Indian consent, child-protection and reporting law with senior or safeguarding support; do not promise secrecy that cannot legally be maintained. Emergency contraception is distinct from medical termination of pregnancy and from the PC-PNDT framework.
Public-health counselling should offer a voluntary ongoing method, condoms and STI prevention without making these conditions of receiving EC. Pharmacy access can improve timeliness but may omit assault screening or follow-up, so written pregnancy-test and red-flag instructions are especially important. No Indian use-rate estimate is asserted because the cited manual does not provide a current nationally representative measure.
NMC Competency Mapping
The NMC Competency Based Medical Education Curriculum 2024 places emergency contraception within Obstetrics and Gynaecology competency OG21.1. The competency asks learners to describe and discuss temporary and permanent methods of contraception, including indications, technique, complications, patient selection, side effects and failure rate, and explicitly names emergency contraception and IUCDs. Emergency contraception therefore belongs within comparative method selection, not as an isolated drug-recall topic.
At the Know and Know How level, a learner should explain the difference between preventing pregnancy and terminating pregnancy; compare copper IUD, ulipristal, levonorgestrel and Yuzpe methods; understand the importance of timing; and identify that ongoing contraception and STI prevention require separate plans. The learner should interpret a focused history, recognise that a very early negative pregnancy test has limits, and use current medical eligibility guidance rather than a memorised list of contraindications from an older manual.
At Show How level in simulation or supervised care, the learner can provide confidential, non-judgemental counselling, calculate elapsed time from each exposure, explain options and uncertainty, check interactions, obtain informed consent, give written follow-up and identify safeguarding or assault needs. Copper-IUD insertion itself also connects to OG21.2, which requires simulated insertion and removal competence; a text guide cannot certify that skill.
Integration includes reproductive physiology, pharmacology, microbiology and STI prevention, emergency care, communication, ethics and Indian law. Assessment should reward safe sequencing and shared decision-making. This guide does not invent a separate NMC code for EC and should be reconciled with the institution’s current competency ledger.
Key Exam Pearls for NEET PG
Emergency contraception prevents pregnancy after intercourse; it is not an abortifacient and does not disrupt an established pregnancy. WHO options are a copper-bearing IUD, ulipristal acetate 30 mg, levonorgestrel 1.5 mg, and the combined Yuzpe regimen. The copper IUD is the most effective method, exceeding 99% effectiveness when inserted within 120 hours, and it becomes ongoing contraception. Oral pills should be taken as soon as possible; ulipristal retains an advantage over other pills in the 72-to-120-hour interval in WHO’s summary.
Mechanisms are high yield. Emergency pills prevent or delay ovulation. Copper impairs sperm and fertilisation. Neither method protects against STI or future intercourse. If vomiting occurs within two hours of an emergency pill, repeat the dose according to WHO advice. A period more than a week late or no bleed by the planned three-week check warrants pregnancy testing. Severe unilateral pain or syncope demands ectopic-pregnancy assessment.
After levonorgestrel, a regular hormonal method may start immediately with appropriate backup. After ulipristal, wait until day six before starting a progestogen-containing method, because progestogen can oppose ulipristal’s effect; use barrier protection through the relevant interval. A copper IUD provides immediate ongoing contraception.
Do not memorise the 2008 Indian manual’s 72-hour wording as the outer limit of all EC. Current WHO guidance uses a five-day window and stresses earlier use. Higher BMI or enzyme-inducing drugs can reduce oral effectiveness, making copper IUD discussion important, but treatment should not be withheld. In assault, add HIV, STI, injury, forensic, psychological and safeguarding care.
Frequently Asked Questions
Does emergency contraception end an already established pregnancy?
No. Emergency contraceptive pills mainly delay or prevent ovulation, and a copper IUD prevents fertilisation. Neither is an abortion method and neither interrupts an established pregnancy. If a pregnancy test is already positive, assess symptoms and pregnancy location, then provide non-directive options counselling. Severe pain, bleeding, fainting or shoulder-tip pain requires urgent ectopic-pregnancy assessment.
Which emergency contraceptive method is the most effective?
A copper-bearing IUD inserted by a trained provider within 120 hours is the most effective option in WHO guidance, with effectiveness above 99%, and it can remain as ongoing contraception. Eligibility, consent, infection risk and uterine factors must be assessed. If it is unsuitable, unavailable or declined, an appropriate oral emergency contraceptive should be offered promptly.
When should regular contraception start after an emergency pill?
After levonorgestrel or a combined emergency regimen, a regular method can generally start or resume immediately, with method-specific barrier backup. After ulipristal, WHO advises starting a progestogen-containing method on day six because earlier progestogen can reduce ulipristal’s effect. Use condoms or abstain during the interval and for the required backup period.
When should a pregnancy test be taken after emergency contraception?
Test if the next period is more than about one week late, is unusually light, or pregnancy symptoms occur; a planned test around three weeks after the latest unprotected intercourse is a practical safety net. Test sooner for a previously missed period. A very early negative test cannot exclude recent conception, and pain, bleeding or collapse requires urgent assessment regardless of the result.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic